#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	304	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1023	15.9	0	.	p	.	0	K29T	NONSYN	85	87	AAG	246	248	ACG	14;14;14	A;C;G	14;14;14	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	170	Chlamydophila_psittaci_16S	1507	109	92.66	Chlamydophila_psittaci_16S.l15.c4.ctg.4	111	15.2	0	.	n	.	0	C897G	SNP	897	897	C	11	11	G	2	G	2	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	170	Chlamydophila_psittaci_16S	1507	109	92.66	Chlamydophila_psittaci_16S.l15.c4.ctg.4	111	15.2	0	.	n	.	0	T898C	SNP	898	898	T	12	12	C	2	C	2	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	170	Chlamydophila_psittaci_16S	1507	109	92.66	Chlamydophila_psittaci_16S.l15.c4.ctg.4	111	15.2	0	.	n	.	0	G906T	SNP	906	906	G	20	20	T	6	T	6	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	170	Chlamydophila_psittaci_16S	1507	109	92.66	Chlamydophila_psittaci_16S.l15.c4.ctg.4	111	15.2	0	.	n	.	0	G908A	SNP	908	908	G	22	22	A	6	A	5	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	170	Chlamydophila_psittaci_16S	1507	109	92.66	Chlamydophila_psittaci_16S.l15.c4.ctg.4	111	15.2	0	.	n	.	0	A918T	SNP	918	918	A	32	32	T	7	T	7	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	170	Chlamydophila_psittaci_16S	1507	109	92.66	Chlamydophila_psittaci_16S.l15.c4.ctg.4	111	15.2	0	.	n	.	0	A943G	SNP	943	943	A	57	57	G	27	G	27	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	170	Chlamydophila_psittaci_16S	1507	109	92.66	Chlamydophila_psittaci_16S.l15.c4.ctg.4	111	15.2	0	.	n	.	0	G991T	SNP	991	991	G	105	105	T	20	T	20	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1184	Escherichia_coli_EF_Tu	1230	1211	99.75	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1375	42.9	1	SNP	p	R234F	1	.	.	700	702	TTC	864	866	TTC	64;61;60	T;T;C	64;60;60	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1184	Escherichia_coli_EF_Tu	1230	1211	99.75	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1375	42.9	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1164	1166	CGT	57;58;59	C;G;T	57;58;59	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1184	Escherichia_coli_EF_Tu	1230	1211	99.75	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1375	42.9	0	HET	.	.	.	C255T	.	255	255	C	419	419	C	36	C,T	22,14	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1184	Escherichia_coli_EF_Tu	1230	69	100.0	Escherichia_coli_EF_Tu.l6.c17.ctg.2	178	4.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	410	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l6.c17.ctg.1	1697	12.9	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1514	1516	AAA	11;10;10	A;A;A	11;10;10	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	514	Escherichia_coli_mutant	1392	1392	99.35	Escherichia_coli_mutant.l15.c30.ctg.1	1643	16.7	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1178	1180	GAA	23;23;24	G;A;A	23;23;24	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	122	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	667	9.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	410	PmrB_1	1092	1092	99.18	PmrB_1.l6.c4.ctg.1	1453	15.0	0	.	p	.	0	H2R	NONSYN	4	6	CAT	211	213	CGT	17;17;17	C;G;T	17;16;17	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	410	PmrB_1	1092	1092	99.18	PmrB_1.l6.c4.ctg.1	1453	15.0	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1054	1056	GGC	27;26;25	G;G;C	27;26;25	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	612	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1958	16.7	0	.	p	.	0	R8S	NONSYN	22	24	AGA	183	185	AGC	5;5;5	A;G;C	5;5;5	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	612	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1958	16.7	0	.	p	.	0	I142L	NONSYN	424	426	ATA	585	587	CTA	15;16;16	C;T;A	15;16;16	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	612	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1958	16.7	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1104	1106	CAA	20;20;20	C;A;A	20;20;20	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	612	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1958	16.7	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1203	1205	GGT	23;24;25	G;G;T	23;24;25	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	612	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1958	16.7	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1773	1775	GTT	8;8;7	G;T;T	8;8;7	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	270	PmrE	1167	1167	96.92	PmrE.l6.c30.ctg.1	1466	9.8	0	.	p	.	0	A125E	NONSYN	373	375	GCA	568	570	GAA	13;13;13	G;A;A	13;13;13	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	270	PmrE	1167	1167	96.92	PmrE.l6.c30.ctg.1	1466	9.8	0	.	p	.	0	M185T	NONSYN	553	555	ATG	748	750	ACC	5;5;4	A;C;C	5;5;4	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	270	PmrE	1167	1167	96.92	PmrE.l6.c30.ctg.1	1466	9.8	0	.	p	.	0	S225T	NONSYN	673	675	TCC	868	870	ACT	5;6;6	A;C;T	5;6;6	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	270	PmrE	1167	1167	96.92	PmrE.l6.c30.ctg.1	1466	9.8	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1258	1260	ATC	4;5;5	A;T;C	4;5;5	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	284	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1372	11.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	888	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3471	13.7	0	.	p	.	0	T85I	NONSYN	253	255	ACC	431	433	ATC	12;12;11	A;T;C	12;12;11	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	888	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3471	13.7	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2144	2146	AAG	17;19;19	A;A;G	17;19;19	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	394	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1431	14.6	0	.	p	.	0	A22V	NONSYN	64	66	GCC	146	148	GTC	5;5;5	G;T;C	5;5;5	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	394	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1431	14.6	0	.	p	.	0	S269C	NONSYN	805	807	AGC	887	889	TGC	24;25;25	T;G;C	24;24;25	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1052	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3189	17.5	0	.	p	.	0	S46trunc	TRUNC	136	136	T	173	173	T	7	T	7	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1052	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3189	17.5	0	.	p	.	0	G148D	NONSYN	442	444	GGC	479	481	GAC	18;17;17	G;A;C	18;17;17	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1052	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3189	17.5	0	.	p	.	0	F240L	NONSYN	718	720	TTT	755	757	TTA	10;9;9	T;T;A	10;9;9	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1052	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3189	17.5	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	1832	1834	AAT	24;24;25	A;A;T	24;24;25	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1052	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3189	17.5	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	1946	1948	AGT	13;13;13	A;G;T	13;13;13	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1052	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3189	17.5	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2345	2347	GTG	15;14;15	G;T;G	15;14;15	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1052	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3189	17.5	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	2900	2902	AAG	20;20;20	A;A;G	20;20;20	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	286	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.1	1031	14.8	1	SNP	p	R45C	0	.	.	133	135	CGC	324	326	CGC	20;20;21	C;G;C	20;20;20	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	234	acrS	663	663	98.79	acrS.l15.c4.ctg.1	916	13.4	0	.	p	.	0	L34F	NONSYN	100	102	CTC	164	166	TTC	16;16;16	T;T;C	16;16;16	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	234	acrS	663	663	98.79	acrS.l15.c4.ctg.1	916	13.4	0	.	p	.	0	E122G	NONSYN	364	366	GAG	428	430	GGG	13;12;13	G;G;G	13;12;13	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	384	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1179	17.4	0	.	p	.	0	V136L	NONSYN	406	408	GTT	633	635	CTT	29;30;30	C;T;T	29;30;30	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	988	alaS	2631	2631	98.94	alaS.l15.c4.ctg.1	3055	17.4	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2082	2084	GCA	13;15;15	G;C;A	13;15;15	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	988	alaS	2631	2631	98.94	alaS.l15.c4.ctg.1	3055	17.4	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2343	2345	ACC	24;23;24	A;C;C	22;22;23	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	988	alaS	2631	2631	98.94	alaS.l15.c4.ctg.1	3055	17.4	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2652	2654	GCC	21;20;23	G;C;C	21;18;23	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	470	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2123	11.5	0	.	p	.	0	G37A	NONSYN	109	111	GGT	181	183	GCT	5;5;5	G;C;T	5;5;5	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	470	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2123	11.5	0	.	p	.	0	D77E	NONSYN	229	231	GAT	301	303	GAG	6;5;5	G;A;G	6;5;5	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	470	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2123	11.5	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	337	339	TGC	6;6;6	T;G;C	6;6;6	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	470	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2123	11.5	0	.	p	.	0	I150V	NONSYN	448	450	ATT	520	522	GTT	9;9;10	G;T;T	9;9;10	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	470	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2123	11.5	0	.	p	.	0	R200H	NONSYN	598	600	CGC	670	672	CAC	9;9;8	C;A;C	9;8;7	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	470	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2123	11.5	0	.	p	.	0	T295M	NONSYN	883	885	ACG	955	957	ATG	14;13;13	A;T;G	13;13;13	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	470	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2123	11.5	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1951	1953	CGC	8;8;8	C;G;C	8;8;8	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	244	bacA	822	822	98.54	bacA.l15.c4.ctg.1	996	12.4	0	.	p	.	0	S221T	NONSYN	661	663	AGC	700	702	ACC	9;9;9	A;C;C	8;9;9	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	244	bacA	822	822	98.54	bacA.l15.c4.ctg.1	996	12.4	0	.	p	.	0	P225S	NONSYN	673	675	CCG	712	714	TCG	9;10;10	T;C;G	8;10;10	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	513	198	baeR	723	513	97.66	baeR.l15.c30.ctg.1	709	12.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	513	198	baeR	723	174	97.7	baeR.l15.c30.ctg.2	179	6.2	0	.	p	.	0	E233K	NONSYN	697	699	GAA	148	150	AAA	3;3;3	A,G;A;A	0,3;3;3	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	368	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1564	12.1	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1275	1277	AAA	6;6;6	A;A;A	6;6;6	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	368	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1564	12.1	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1287	1289	GAG	7;8;8	G;A;G	7;8;8	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	368	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1564	12.1	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1293	1295	CAC	8;8;8	C;A;C	8;8;8	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	368	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1564	12.1	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1347	1349	GAG	14;14;14	G;A;G	14;14;14	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	586	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1803	17.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	304	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1183	13.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	27	260	cysB	975	975	99.38	cysB.l15.c4.ctg.1	1247	11.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	342	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1221	14.4	0	.	p	.	0	W42C	NONSYN	124	126	TGG	159	161	TGT	12;12;11	T;G;T	12;12;11	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	342	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1221	14.4	0	.	p	.	0	I219V	NONSYN	655	657	ATC	690	692	GTC	16;16;15	G;T;C	16;16;14	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	500	emrB	1539	1539	99.81	emrB.l15.c17.ctg.1	1919	14.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	366	emrD	1191	1191	98.49	emrD.l15.c30.ctg.1	1451	13.3	0	.	p	.	0	G209S	NONSYN	625	627	GGC	764	766	AGC	13;13;12	A;G;C	13;13;12	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	366	emrD	1191	1191	98.49	emrD.l15.c30.ctg.1	1451	13.3	0	.	p	.	0	Q345L	NONSYN	1033	1035	CAA	1172	1174	CTA	2;2;2	C;T,A;A	2;0,2;2	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	20	emrE_1	333	77	96.1	emrE_1.l15.c4.ctg.1	77	7.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	326	emrK	1056	1056	98.2	emrK.l6.c30.ctg.1	1473	11.9	0	.	p	.	0	K176R	NONSYN	526	528	AAG	722	724	AGG	6;6;6	A;G;G	6;6;6	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	326	emrK	1056	1056	98.2	emrK.l6.c30.ctg.1	1473	11.9	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1112	1114	GAC	8;8;7	G;A;C	8;8;7	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	200	emrR	531	531	100.0	emrR.l15.c4.ctg.1	943	11.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	450	emrY	1539	1539	99.81	emrY.l15.c17.ctg.1	1917	12.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	198	evgA	615	615	99.19	evgA.l15.c4.ctg.1	677	13.2	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	198	200	CTG	5;6;6	C;T;G	5;6;6	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	938	evgS	3594	919	97.28	evgS.l15.c4.ctg.1	995	12.0	0	.	p	.	0	T38I	NONSYN	112	114	ACA	188	190	ATA	5;5;5	A;T;A	5;5;5	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	938	evgS	3594	919	97.28	evgS.l15.c4.ctg.1	995	12.0	0	.	p	.	0	L42V	NONSYN	124	126	CTA	200	202	GTA	4;4;4	G;T;A	4;4;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	938	evgS	3594	919	97.28	evgS.l15.c4.ctg.1	995	12.0	0	.	p	.	0	A93T	NONSYN	277	279	GCG	353	355	ACG	12;12;13	A;C;G	12;12;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	938	evgS	3594	919	97.28	evgS.l15.c4.ctg.1	995	12.0	0	.	p	.	0	A114E	NONSYN	340	342	GCA	416	418	GAA	17;16;15	G;A;A	17;16;15	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	938	evgS	3594	919	97.28	evgS.l15.c4.ctg.1	995	12.0	0	.	p	.	0	T127A	NONSYN	379	381	ACT	455	457	GCT	10;10;10	G;C;T	10;10;10	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	938	evgS	3594	919	97.28	evgS.l15.c4.ctg.1	995	12.0	0	.	p	.	0	N133D	NONSYN	397	399	AAT	473	475	GAT	12;12;12	G;A;T	12;12;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	938	evgS	3594	919	97.28	evgS.l15.c4.ctg.1	995	12.0	0	.	p	.	0	P162S	NONSYN	484	486	CCA	560	562	TCA	9;9;7	T;C;A	9;9;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	938	evgS	3594	919	97.28	evgS.l15.c4.ctg.1	995	12.0	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	689	691	CAG	7;7;7	C;A;G	7;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	938	evgS	3594	919	97.28	evgS.l15.c4.ctg.1	995	12.0	0	.	p	.	0	I251V	NONSYN	751	753	ATT	827	829	GTT	7;7;7	G;T;T	7;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	938	evgS	3594	919	97.28	evgS.l15.c4.ctg.1	995	12.0	0	.	p	.	0	N303D	NONSYN	907	909	AAT	983	985	GAT	4;4;2	G;A;T	4;4;2	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	938	evgS	3594	2630	97.68	evgS.l15.c4.ctg.2	2823	13.5	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	111	113	AAT	8;8;8	A;A;T	8;8;8	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	938	evgS	3594	2630	97.68	evgS.l15.c4.ctg.2	2823	13.5	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	132	134	TTA	2;2;2	T;T;A	2;2;2	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	938	evgS	3594	2630	97.68	evgS.l15.c4.ctg.2	2823	13.5	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	333	335	AAA	7;7;7	A;A;A	7;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	938	evgS	3594	2630	97.68	evgS.l15.c4.ctg.2	2823	13.5	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	1068	1070	CAT	12;12;12	C;A;T	12;12;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	938	evgS	3594	2630	97.68	evgS.l15.c4.ctg.2	2823	13.5	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	1122	1124	CAT	12;13;13	C;A;T	12;13;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	938	evgS	3594	2630	97.68	evgS.l15.c4.ctg.2	2823	13.5	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	1140	1142	AGA	10;11;11	A;G;A	10;11;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	938	evgS	3594	2630	97.68	evgS.l15.c4.ctg.2	2823	13.5	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1155	1157	AAT	11;11;11	A;A;T	11;11;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	938	evgS	3594	2630	97.68	evgS.l15.c4.ctg.2	2823	13.5	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1302	1304	TCC	8;7;7	T;C;C	8;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	938	evgS	3594	2630	97.68	evgS.l15.c4.ctg.2	2823	13.5	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1467	1469	ATT	14;14;12	A;T;T	14;14;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	938	evgS	3594	2630	97.68	evgS.l15.c4.ctg.2	2823	13.5	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1488	1490	GAT	8;8;9	G;A;T	8;8;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	938	evgS	3594	2630	97.68	evgS.l15.c4.ctg.2	2823	13.5	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1602	1604	GTT	17;17;17	G;T;T	17;17;17	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	938	evgS	3594	2630	97.68	evgS.l15.c4.ctg.2	2823	13.5	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1887	1889	CAC	14;14;14	C;A;C	13;14;14	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	274	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1151	12.6	1	SNP	p	P64A	0	.	.	190	192	CCA	271	273	CCA	26;25;25	C;C;A	26;25;25	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	274	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1151	12.6	1	SNP	p	P64R	0	.	.	190	192	CCA	271	273	CCA	26;25;25	C;C;A	26;25;25	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	274	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1151	12.6	1	SNP	p	P64H	0	.	.	190	192	CCA	271	273	CCA	26;25;25	C;C;A	26;25;25	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	274	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1151	12.6	1	SNP	p	P64L	0	.	.	190	192	CCA	271	273	CCA	26;25;25	C;C;A	26;25;25	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	274	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1151	12.6	1	SNP	p	P64S	0	.	.	190	192	CCA	271	273	CCA	26;25;25	C;C;A	26;25;25	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	188	gadE	528	528	100.0	gadE.l6.c30.ctg.1	999	10.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	72	gadW	729	153	93.46	gadW.l15.c30.ctg.2	154	2.8	0	.	p	.	0	E54D	NONSYN	160	162	GAA	23	25	GAT	2;2;2	G;A;T	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	72	gadW	729	153	93.46	gadW.l15.c30.ctg.2	154	2.8	0	.	p	.	0	I88M	NONSYN	262	264	ATA	125	127	ATG	2;2;2	A;T;G	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	72	gadW	729	153	93.46	gadW.l15.c30.ctg.2	154	2.8	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	128	130	CCG	2;1;1	C;C;G	2;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	208	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1003	10.9	0	.	p	.	0	F53L	NONSYN	157	159	TTC	303	305	TTA	12;12;12	T;T;A	12;12;12	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	208	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1003	10.9	0	.	p	.	0	V79I	NONSYN	235	237	GTT	381	383	ATT	11;10;9	A;T;T	11;10;9	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	208	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1003	10.9	0	.	p	.	0	R246G	NONSYN	736	738	AGA	882	884	GGA	8;7;7	G;G;A	8;7;7	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	208	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1003	10.9	0	.	p	.	0	S248P	NONSYN	742	744	TCG	888	890	CCG	7;7;9	C;C;G	7;7;9	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	990	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2903	18.0	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2106	2108	GAA	17;17;17	G;A;A	17;17;17	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	990	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2903	18.0	1	SNP	p	S83W	0	.	.	247	249	TCG	321	323	TCG	17;17;15	T;C;G	17;16;15	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	990	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2903	18.0	1	SNP	p	S83I	0	.	.	247	249	TCG	321	323	TCG	17;17;15	T;C;G	17;16;15	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	990	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2903	18.0	1	SNP	p	S83L	0	.	.	247	249	TCG	321	323	TCG	17;17;15	T;C;G	17;16;15	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	990	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2903	18.0	1	SNP	p	D87G	0	.	.	259	261	GAC	333	335	GAC	16;16;15	G;A;C	16;16;15	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	990	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2903	18.0	1	SNP	p	D87H	0	.	.	259	261	GAC	333	335	GAC	16;16;15	G;A;C	16;16;15	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	990	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2903	18.0	1	SNP	p	D87Y	0	.	.	259	261	GAC	333	335	GAC	16;16;15	G;A;C	16;16;15	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	990	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2903	18.0	1	SNP	p	D87N	0	.	.	259	261	GAC	333	335	GAC	16;16;15	G;A;C	16;16;15	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	990	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2903	18.0	1	SNP	p	D87V	0	.	.	259	261	GAC	333	335	GAC	16;16;15	G;A;C	16;16;15	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	539	886	gyrB_1	2415	2415	99.09	gyrB_1.l6.c4.ctg.1	2798	17.0	0	.	p	.	0	S645N	NONSYN	1933	1935	AGC	2120	2122	AAC	15;14;13	A;A;C	15;12;13	.	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	539	886	gyrB_1	2415	2415	99.09	gyrB_1.l6.c4.ctg.1	2798	17.0	1	SNP	p	R136I	0	.	.	406	408	CGC	593	595	CGC	16;16;16	C;G;C	16;16;16	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	539	886	gyrB_1	2415	2415	99.09	gyrB_1.l6.c4.ctg.1	2798	17.0	1	SNP	p	R136C	0	.	.	406	408	CGC	593	595	CGC	16;16;16	C;G;C	16;16;16	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	539	886	gyrB_1	2415	2415	99.09	gyrB_1.l6.c4.ctg.1	2798	17.0	1	SNP	p	R136E	0	.	.	406	408	CGC	593	595	CGC	16;16;16	C;G;C	16;16;16	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	539	886	gyrB_1	2415	2415	99.09	gyrB_1.l6.c4.ctg.1	2798	17.0	1	SNP	p	R136G	0	.	.	406	408	CGC	593	595	CGC	16;16;16	C;G;C	16;16;16	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	539	886	gyrB_1	2415	2415	99.09	gyrB_1.l6.c4.ctg.1	2798	17.0	1	SNP	p	R136S	0	.	.	406	408	CGC	593	595	CGC	16;16;16	C;G;C	16;16;16	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	539	886	gyrB_1	2415	2415	99.09	gyrB_1.l6.c4.ctg.1	2798	17.0	1	SNP	p	R136L	0	.	.	406	408	CGC	593	595	CGC	16;16;16	C;G;C	16;16;16	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	539	886	gyrB_1	2415	2415	99.09	gyrB_1.l6.c4.ctg.1	2798	17.0	1	SNP	p	R136H	0	.	.	406	408	CGC	593	595	CGC	16;16;16	C;G;C	16;16;16	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	188	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	879	10.5	0	.	p	.	0	A72P	NONSYN	214	216	GCG	290	292	CCG	16;16;16	C;C,G;G	16;15,1;16	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	188	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	879	10.5	0	.	p	.	0	T123A	NONSYN	367	369	ACC	443	445	GCC	11;11;11	G;C;C	11;11;11	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	438	leuO	945	945	99.26	leuO.l6.c4.ctg.1	1246	18.8	0	.	p	.	0	P9S	NONSYN	25	27	CCA	139	141	TCA	11;12;11	T;C;A	11;12;11	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	150	marA	384	384	99.74	marA.l15.c4.ctg.1	784	10.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	106	marR	435	427	97.66	marR.l15.c30.ctg.1	520	9.4	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	400	402	AGC	11;11;11	A;G;C	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	106	marR	435	427	97.66	marR.l15.c30.ctg.1	520	9.4	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	502	504	CAT	2;1;1	C;A;T	2;1;1	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	106	marR	435	427	97.66	marR.l15.c30.ctg.1	520	9.4	1	SNP	p	V45E	0	.	.	133	135	GTG	226	228	GTG	18;18;18	G;T;G	17;17;18	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	106	marR	435	427	97.66	marR.l15.c30.ctg.1	520	9.4	1	SNP	p	I49S	0	.	.	145	147	ATC	238	240	ATC	15;15;14	A;T;C	14;15;13	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	106	marR	435	427	97.66	marR.l15.c30.ctg.1	520	9.4	1	SNP	p	A70T	0	.	.	208	210	GCA	301	303	GCA	10;10;10	G;C;A	10;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	106	marR	435	427	97.66	marR.l15.c30.ctg.1	520	9.4	1	SNP	p	R73C	0	.	.	217	219	CGT	310	312	CGT	9;9;9	C;G;T	9;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	106	marR	435	427	97.66	marR.l15.c30.ctg.1	520	9.4	1	SNP	p	R73S	0	.	.	217	219	CGT	310	312	CGT	9;9;9	C;G;T	9;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	106	marR	435	427	97.66	marR.l15.c30.ctg.1	520	9.4	1	SNP	p	R77C	0	.	.	229	231	CGC	322	324	CGC	6;5;5	C;G;C	6;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	106	marR	435	427	97.66	marR.l15.c30.ctg.1	520	9.4	1	SNP	p	R77L	0	.	.	229	231	CGC	322	324	CGC	6;5;5	C;G;C	6;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	106	marR	435	427	97.66	marR.l15.c30.ctg.1	520	9.4	1	SNP	p	L78M	0	.	.	232	234	CTG	325	327	CTG	3;3;3	C;T;G	3;3;3	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	106	marR	435	427	97.66	marR.l15.c30.ctg.1	520	9.4	1	SNP	p	R94S	0	.	.	280	282	CGC	373	375	CGC	10;10;10	C;G;C	10;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	106	marR	435	427	97.66	marR.l15.c30.ctg.1	520	9.4	1	SNP	p	R94H	0	.	.	280	282	CGC	373	375	CGC	10;10;10	C;G;C	10;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	106	marR	435	427	97.66	marR.l15.c30.ctg.1	520	9.4	1	SNP	p	V96E	0	.	.	286	288	GTA	379	381	GTA	10;10;11	G;T;A	10;10;11	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	302	mdfA	1233	1027	97.18	mdfA.l6.c4.ctg.1	1195	12.2	0	.	p	.	0	G88fs	FSHIFT	262	262	G	56	56	G	12	G	12	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	302	mdfA	1233	183	93.99	mdfA.l6.c4.ctg.3	185	6.1	0	.	p	.	0	S7F	NONSYN	19	21	TCC	21	23	TTC	2;2;2	T;T;C	2;2;2	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	302	mdfA	1233	183	93.99	mdfA.l6.c4.ctg.3	185	6.1	0	.	p	.	0	R36I	NONSYN	106	108	AGG	108	110	ATC	14;14;13	A;T;C	14;14;13	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	302	mdfA	1233	183	93.99	mdfA.l6.c4.ctg.3	185	6.1	0	.	p	.	0	E42A	NONSYN	124	126	GAA	126	128	GCC	5;5;5	G;C;C	5;5;5	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	302	mdfA	1233	183	93.99	mdfA.l6.c4.ctg.3	185	6.1	0	.	p	.	0	N43V	NONSYN	127	129	AAT	129	131	GTG	5;5;5	G;T;G	5;5;5	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	302	mdfA	1233	183	93.99	mdfA.l6.c4.ctg.3	185	6.1	0	.	p	.	0	E52D	NONSYN	154	156	GAG	156	158	GAT	3;3;3	G;A;T	3;3;3	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	302	mdfA	1233	183	93.99	mdfA.l6.c4.ctg.3	185	6.1	0	.	p	.	0	N59T	NONSYN	175	177	AAC	177	179	ACC	1;1;1	A;C;C	1;1;1	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	270	mdtA	1248	984	97.87	mdtA.l15.c4.ctg.1	1154	10.0	0	.	p	.	0	I99M	NONSYN	295	297	ATA	31	33	ATG	8;8;8	A;T;G	8;8;8	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	270	mdtA	1248	984	97.87	mdtA.l15.c4.ctg.1	1154	10.0	0	.	p	.	0	A130T	NONSYN	388	390	GCC	124	126	ACC	8;8;7	A;C;C	8;8;7	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	270	mdtA	1248	254	96.06	mdtA.l15.c4.ctg.2	273	7.7	0	.	p	.	0	V12trunc	TRUNC	34	34	G	59	59	G	12	G	12	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	270	mdtA	1248	254	96.06	mdtA.l15.c4.ctg.2	273	7.7	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	116	118	CAG	8;8;6	C;A;G	8;8;6	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	270	mdtA	1248	254	96.06	mdtA.l15.c4.ctg.2	273	7.7	0	.	p	.	0	T83I	NONSYN	247	249	ACC	266	268	ATC	5;4;3	A;T;C	5;4;3	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1040	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3384	16.5	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1951	1953	ACC	17;17;16	A;C;C	17;17;16	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1040	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3384	16.5	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2344	2346	CAA	16;16;16	C;A;A	15;16;15	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1040	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3384	16.5	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2512	2514	ATT	7;7;6	A;T;T	7;7;6	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1040	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3384	16.5	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2596	2598	GTT	12;12;12	G;T;T	12;12;12	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1040	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3384	16.5	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2704	2706	GAG	10;10;10	G;A;G	10;10;10	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1040	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3384	16.5	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2932	2934	ATG	12;13;13	A;T;G	12;13;12	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1040	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3384	16.5	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3067	3069	GAT	14;14;15	G;A;T,C	14;14;13,1	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	896	mdtC	3078	3078	98.73	mdtC.l6.c4.ctg.1	3289	14.3	0	.	p	.	0	I46M	NONSYN	136	138	ATC	325	327	ATG	9;8;7	A;T;G	8;8;7	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	896	mdtC	3078	3078	98.73	mdtC.l6.c4.ctg.1	3289	14.3	0	.	p	.	0	V208I	NONSYN	622	624	GTC	811	813	ATC	15;16;16	A;T;C	15;16;16	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	896	mdtC	3078	3078	98.73	mdtC.l6.c4.ctg.1	3289	14.3	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3127	3129	CAC	5;5;5	C;A;C	5;5;5	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	380	mdtD	1416	1416	98.47	mdtD.l6.c4.ctg.1	1554	12.0	0	.	p	.	0	T226A	NONSYN	676	678	ACG	636	638	GCG	17;18;18	G;C;G	17;18;18	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	380	mdtD	1416	1416	98.47	mdtD.l6.c4.ctg.1	1554	12.0	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	978	980	ATC	14;12;13	A;T;C	13;12;13	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	380	mdtD	1416	1416	98.47	mdtD.l6.c4.ctg.1	1554	12.0	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1281	1283	TTT	15;15;15	T;T;T	15;15;15	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	430	mdtE	1158	1158	99.31	mdtE.l15.c30.ctg.1	1394	16.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1112	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3432	17.3	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1028	1030	ACC	16;16;16	A;C;C	16;15;16	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1112	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3432	17.3	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2270	2272	GAC	14;14;14	G;A;C	13;13;14	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	426	mdtG	1227	1047	99.43	mdtG.l15.c4.ctg.1	1408	13.6	0	.	p	.	0	V200I	NONSYN	598	600	GTC	600	602	ATC	21;22;22	A;T;C	21;22;22	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	426	mdtG	1227	173	99.42	mdtG.l15.c4.ctg.2	293	8.2	0	.	p	.	0	E5G	NONSYN	13	15	GAA	4	6	GGA	4;6;7	G;G;A	4;6;7	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	358	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.2	1381	13.3	0	.	p	.	0	G134C	NONSYN	400	402	GGT	552	554	TGT	18;19;19	T;G;T	18;19;19	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	358	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.2	1381	13.3	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1122	1124	TTG	8;9;10	T;T;G	8;9;10	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	358	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.2	1381	13.3	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1332	1334	ACG	3;3;3	A;C;G	3;3;3	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	358	mdtL	1176	1176	98.38	mdtL.l15.c30.ctg.1	1309	13.9	0	.	p	.	0	A185S	NONSYN	553	555	GCC	670	672	TCC	13;14;13	T;C;C	13;14;13	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	350	mdtN	1032	1032	98.06	mdtN.l15.c4.ctg.1	1288	13.4	0	.	p	.	0	V119I	NONSYN	355	357	GTT	544	546	ATT	13;13;13	A;T;T	13;13;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	702	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2256	16.5	0	.	p	.	0	V11M	NONSYN	31	33	GTG	89	91	ATG	14;15;15	A;T;G	14;15;15	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	702	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2256	16.5	0	.	p	.	0	T33I	NONSYN	97	99	ACC	155	157	ATC	8;7;6	A;T;C	8;7;6	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	702	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2256	16.5	0	.	p	.	0	C116R	NONSYN	346	348	TGC	404	406	CGC	23;24;25	C;G;C	23;24;25	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	702	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2256	16.5	0	.	p	.	0	N238S	NONSYN	712	714	AAC	770	772	AGC	22;21;21	A;G;C	21;20;19	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	702	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2256	16.5	0	.	p	.	0	M305V	NONSYN	913	915	ATG	971	973	GTG	20;18;18	G;T;G	20;18;18	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	702	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2256	16.5	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1034	1036	AAC	4;4;4	A;A;C	4;4;4	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	702	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2256	16.5	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1079	1081	GTC	11;11;11	G;T;C	11;10;11	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	702	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2256	16.5	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1109	1111	ATA	17;15;15	A;T;A	17;15;15	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	702	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2256	16.5	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1217	1219	TCT	10;11;11	T;C;T	10;11;11	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	702	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2256	16.5	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1604	1606	GCG	14;13;14	G;C;G	14;12;14	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	702	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2256	16.5	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1817	1819	ATC	16;17;16	A;T;C	16;17;16	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	384	mdtP	1467	1467	97.89	mdtP.l6.c4.ctg.1	1523	12.9	0	.	p	.	0	Q68trunc	TRUNC	202	202	C	217	217	T	24	T	24	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	384	mdtP	1467	1467	97.89	mdtP.l6.c4.ctg.1	1523	12.9	0	.	p	.	0	S129A	NONSYN	385	387	TCA	400	402	GCG	8;8;8	G;C;G	8;8;8	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	384	mdtP	1467	1467	97.89	mdtP.l6.c4.ctg.1	1523	12.9	0	.	p	.	0	A187T	NONSYN	559	561	GCC	574	576	ACC	8;7;7	A;C;C	8;7;7	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	384	mdtP	1467	1467	97.89	mdtP.l6.c4.ctg.1	1523	12.9	0	.	p	.	0	H211R	NONSYN	631	633	CAC	646	648	CGC	13;13;13	C;G,T;C	12;12,1;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	384	mdtP	1467	1467	97.89	mdtP.l6.c4.ctg.1	1523	12.9	0	.	p	.	0	V250A	NONSYN	748	750	GTT	763	765	GCT	10;11;11	G;C;T	10;11;11	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	384	mdtP	1467	1467	97.89	mdtP.l6.c4.ctg.1	1523	12.9	0	.	p	.	0	R278K	NONSYN	832	834	AGA	847	849	AAA	6;5;5	A;A;A	6;5;5	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	384	mdtP	1467	1467	97.89	mdtP.l6.c4.ctg.1	1523	12.9	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	865	867	CGA	9;9;9	C;G;A	9;9;9	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	384	mdtP	1467	1467	97.89	mdtP.l6.c4.ctg.1	1523	12.9	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1030	1032	GCC	9;9;9	G;C;C	9;9;9	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	384	mdtP	1467	1467	97.89	mdtP.l6.c4.ctg.1	1523	12.9	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1042	1044	GAT	9;9;9	G;A;T	9;9;9	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	384	mdtP	1467	1467	97.89	mdtP.l6.c4.ctg.1	1523	12.9	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1459	1461	GCT	3;3;3	G;C;T	3;3;3	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1168	mfd	3447	3447	99.16	mfd.l6.c30.ctg.1	3894	16.1	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1518	1520	AAG	12;13;13	A;A;G	12;13;12	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1168	mfd	3447	3447	99.16	mfd.l6.c30.ctg.1	3894	16.1	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2595	2597	CTG	11;10;10	C;T;G	11;10;10	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	84	mgrB	144	144	100.0	mgrB.l15.c4.ctg.1	165	13.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	660	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	1908	18.3	0	.	p	.	0	S278N	NONSYN	832	834	AGC	933	935	AAC	14;14;14	A;A;C	14;14;14	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	660	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	1908	18.3	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1479	1481	ATA	17;17;18	A;T;A	17;17;18	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	452	murA_12	1260	1260	98.57	murA_12.l15.c4.ctg.1	1629	14.8	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1297	1299	GAT	18;17;17	G;A;T	18;17;17	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	452	murA_12	1260	1260	98.57	murA_12.l15.c4.ctg.1	1629	14.8	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1300	1302	CTG	16;16;14	C;T;G	16;15;14	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	210	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1117	10.1	0	.	p	.	0	R27C	NONSYN	79	81	CGT	264	266	TGT	3;3;3	T;G;T	3;3;3	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	210	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1117	10.1	0	.	p	.	0	I117T	NONSYN	349	351	ATC	534	536	ACC	20;20;20	A;C;C	20;20;20	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	210	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1117	10.1	0	.	p	.	0	G187D	NONSYN	559	561	GGC	744	746	GAC	11;11;11	G;A;C	11;11;11	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	210	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1117	10.1	1	SNP	p	R15C	0	.	.	43	45	CGC	228	230	CGC	12;12;12	C;G;C	12;12;12	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	210	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1117	10.1	1	SNP	p	S33R	0	.	.	97	99	AGC	282	284	AGC	6;6;6	A;G;C	6;6;6	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	210	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1117	10.1	1	SNP	p	G131D	0	.	.	391	393	GGC	576	578	GGC	16;16;16	G;G;C	15;15;15	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	210	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1117	10.1	1	SNP	p	R203L	0	.	.	607	609	CGT	792	794	CGT	10;12;12	C;G;T	10;12;12	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	210	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1117	10.1	1	SNP	p	R203C	0	.	.	607	609	CGT	792	794	CGT	10;12;12	C;G;T	10;12;12	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	514	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1494	18.4	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1111	1113	GAG	24;22;22	G;A;G	24;22;21	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	514	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1494	18.4	1	SNP	p	G141E	0	.	.	421	423	GGT	598	600	GGT	24;24;23	G;G;T	24;24;23	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	514	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1494	18.4	1	SNP	p	G141D	0	.	.	421	423	GGT	598	600	GGT	24;24;23	G;G;T	24;24;23	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	514	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1494	18.4	1	SNP	p	R154A	0	.	.	460	462	CGT	637	639	CGT	21;22;21	C;G;T	21;22;21	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	514	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1494	18.4	1	SNP	p	R154D	0	.	.	460	462	CGT	637	639	CGT	21;22;21	C;G;T	21;22;21	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003939.NC_003197.1.3336946_3339205.3739	parC.3003939.NC_003197.1.3336946_3339205.3739	1	1	16	84	parC_3	2259	111	97.3	parC_3.l15.c4.ctg.2	131	13.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Salmonella enterica parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	958	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2738	18.8	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1890	1892	TCG	19;19;19	T;C;G	19;18;19	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	958	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2738	18.8	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2505	2507	AAC	16;16;16	A;A;C	16;16;16	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	958	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2738	18.8	1	SNP	p	A85T	0	.	.	253	255	GCG	519	521	GCG	27;27;28	G;C;G	26;26;28	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	958	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2738	18.8	1	SNP	p	D111H	0	.	.	331	333	GAT	597	599	GAT	10;10;10	G;A;T	10;10;10	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	958	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2738	18.8	1	SNP	p	S129P	0	.	.	385	387	TCC	651	653	TCC	23;24;24	T;C;C	21;23;23	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	515	526	parE_1	1893	1743	97.42	parE_1.l15.c4.ctg.1	1934	13.5	0	.	p	.	0	D476A	NONSYN	1426	1428	GAT	1276	1278	GCT	16;16;16	G;C;T	16;16;16	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	515	526	parE_1	1893	122	99.18	parE_1.l15.c4.ctg.2	154	9.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	488	patA	1380	1380	99.86	patA.l6.c4.ctg.1	1903	13.7	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1323	1325	GAT	20;19;20	G;A;T	20;19;20	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1864	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4407	22.7	1	SNP	p	V146F	0	.	.	436	438	GTT	657	659	GTT	19;19;18	G;T;T	19;19;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1864	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4407	22.7	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1758	1760	CAG	18;19;20	C;A;G	18;19;20	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1864	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4407	22.7	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1758	1760	CAG	18;19;20	C;A;G	18;19;20	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1864	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4407	22.7	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1797	1799	CAC	19;20;20	C;A;C	19;20;20	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1864	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4407	22.7	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1806	1808	CGT	21;21;18	C;G;T	21;21;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1864	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4407	22.7	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1806	1808	CGT	21;21;18	C;G;T	21;21;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1864	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4407	22.7	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1812	1814	TCC	19;18;17	T;C;C	19;18;17	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1864	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4407	22.7	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1818	1820	CTC	15;15;14	C;T;C	15;15;14	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1864	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4407	22.7	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1908	1910	ACC	22;22;24	A;C;C	22;22;24	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1864	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4407	22.7	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1911	1913	CCT	24;24;24	C;C;T	24;24;24	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1864	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4407	22.7	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2280	2282	CGT	28;27;27	C;G;T	28;27;27	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1187	115.7	0	.	n	.	0	A226G	SNP	226	226	A	413	413	G	162	G	162	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1187	115.7	1	SNP	n	A794G	0	.	.	794	794	A	981	981	A	124	A	124	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1187	115.7	1	SNP	n	A794T	0	.	.	794	794	A	981	981	A	124	A	124	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1187	115.7	1	SNP	n	G926T	0	.	.	926	926	G	1113	1113	G	131	G	129	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1187	115.7	1	SNP	n	G926C	0	.	.	926	926	G	1113	1113	G	131	G	129	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1187	115.7	1	SNP	n	G926A	0	.	.	926	926	G	1113	1113	G	131	G	129	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1187	115.7	0	HET	.	.	.	A79G	.	79	79	A	266	266	A	126	A,G	90,36	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1187	115.7	0	HET	.	.	.	C719T	.	719	719	C	906	906	C	97	C,T	53,44	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1187	115.7	0	HET	.	.	.	T273A	.	273	273	T	460	460	T	114	T,A	85,27	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1187	115.7	0	HET	.	.	.	C183T	.	183	183	C	370	370	C	121	C,T	76,43	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1187	115.7	0	HET	.	.	.	A250T	.	250	250	A	437	437	A	132	A,T	102,29	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1187	115.7	0	HET	.	.	.	T90C	.	90	90	T	277	277	T	128	T,C	95,32	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1187	115.7	0	HET	.	.	.	G474A	.	474	474	G	661	661	G	136	G,A	105,30	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1187	115.7	0	HET	.	.	.	A253T	.	253	253	A	440	440	A	132	A,T	102,29	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	1000	99.9	rrsB+.l15.c17.ctg.1	1187	115.7	0	HET	.	.	.	C194T	.	194	194	C	381	381	C	138	C,T	105,33	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	500	100.0	rrsB+.l15.c17.ctg.2	513	146.5	1	SNP	n	A1519C	0	.	.	1519	1519	A	477	477	A	104	A	102	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	500	100.0	rrsB+.l15.c17.ctg.2	513	146.5	1	SNP	n	A1519G	0	.	.	1519	1519	A	477	477	A	104	A	102	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	500	100.0	rrsB+.l15.c17.ctg.2	513	146.5	1	SNP	n	A1519T	0	.	.	1519	1519	A	477	477	A	104	A	102	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	143	100.0	rrsB+.l15.c17.ctg.3	143	29.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	141	95.07	rrsB+.l15.c17.ctg.5	141	22.6	0	.	n	.	0	G1002A	SNP	1002	1002	G	52	52	A	41	A	41	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	141	95.07	rrsB+.l15.c17.ctg.5	141	22.6	0	.	n	.	0	G1006C	SNP	1006	1006	G	56	56	C	45	C	45	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	141	95.07	rrsB+.l15.c17.ctg.5	141	22.6	0	.	n	.	0	T1010C	SNP	1010	1010	T	60	60	C	49	C	49	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	141	95.07	rrsB+.l15.c17.ctg.5	141	22.6	0	.	n	.	0	A1019.	DEL	1019	1019	A	68	68	G	47	G	47	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	141	95.07	rrsB+.l15.c17.ctg.5	141	22.6	0	.	n	.	0	.1023G	INS	1023	1023	T	73	73	G	43	G	43	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4372	rrsB+	1542	141	95.07	rrsB+.l15.c17.ctg.5	141	22.6	0	.	n	.	0	C1038T	SNP	1038	1038	C	88	88	T	33	T	33	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	228	soxR	465	465	100.0	soxR.l15.c30.ctg.1	839	14.4	1	SNP	p	R20H	0	.	.	58	60	CGC	232	234	CGC	18;18;19	C;G;C	17;18;19	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	228	soxR	465	465	100.0	soxR.l15.c30.ctg.1	839	14.4	1	SNP	p	G121D	0	.	.	361	363	GGT	535	537	GGT	24;23;23	G;G;T	24;23;23	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	138	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	720	10.0	1	SNP	p	A12S	0	.	.	34	36	GCA	232	234	GCA	22;23;21	G;C;A	22;23;20	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	464	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	1756	13.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
